SOHM Inc (SHMN)

[MDPennyPlayer]

Filing is out. So much for those outlandish revenue predictions

[hardlesson]

Good question. It looks like they "attended" DCAT week in March:

We are attending DCAT week at New York, please see below and get in touch for CDMO, Levetiracetam, Topical products, etc. #DCATweek#Levetiracetam #CDMO$SHMN pic.twitter.com/0lXrJbsMIh

— SOHM, Inc. (@sohminc) March 6, 2024

They "presented" at AACR in April:

We’re thrilled to announce that our presentation at #AACR was met with an exceptional reception. It was an honor to showcase our technology to esteemed researchers and leaders in the biotech industry.

The overwhelming interest and impact generated by our innovation have been… pic.twitter.com/50Ggv6hqPj

— SOHM, Inc. (@sohminc) April 9, 2024

They were supposed to "participate" at Synbiobeta 2024 on May 6-9:
"Interim scientific results from R&D will be available during SOHM’s participation at:
May 2024: SynbioBeta 2024 in San Jose, CA"
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Announces-Business-Outlook-for-2024?id=423706

BUT, we didn't hear Sohm (not that I recall) making any announcements in the build-up to the event, and haven't heard if they cancelled, or attended, presented, or participated. My guess? is they didn't "SPEAK" at the event, since Sohm, or Aguilar are not listed on the Synbiobeta 2024 website.

Maybe they will see our posts and fill us in at some point? hL shmn Baby Pharma at .0012 :)

[SLC-JD]

Which begs the question, how definitive was it?

[MPstock]

No prize, just a friendly bet

[Myth]

so what's the big prize MP, one of those giant lolliops ??



well gl anyway....

[Myth]

I guess it doesn't matter now being it was 2021, I just feel as though they didn't " get over their skis " as the Definitive agreement was announced..

https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Signed-a-Definitive-Agreement-for-Acquisition-of-Californian-Pharmaceutical-Company?id=323160

Now what actually happened as far as why it broke down was never explained although I was told the seller wanted more money which should have costed them in penalties.

Did it ? Who knows....

[SLC-JD]

It's been a good couple of years, that's for sure. Before that, pretty hit or miss.

Snowbird is still open, and from the look of things, several other areas *could* have stayed open had they wanted to (by this time of year, most of the skiers have season passes, so there's little financial incentive to keep operating)

[SLC-JD]

Yes, and the lack of disclosure was a major concern of mine during this period.

That said, a LOI is not a definitive agreement, and based on what they did disclose, the definitive was never executed (they seemed to have a couple of 'agreements to agree', which are unenforceable and thus not definitive).

[MDPennyPlayer]

Synbiobeta conference was last week.

https://www.synbiobeta.com/attend/synbiobeta-2024#speakers

Wasn't Sohm touting their participation at the conference a few months ago?

[ChartTRACKER]

$SHMN: MPSTOCK: Now having said all of that...
Let's give some credit where it's due.
1. ABBIE (Gene Editing) acquisition of IP will take this Co to a different playing field.

2. ABBIE & CoStar's Red blood cell membrane will make this COMBO as a SUPERIOR mode of Bioavailability...meaning that this combo will simply outperform other types of gene therapy delivery (Most drugs FAIL in the realm of Bioavailability, they show promise in a petri-dish...but...)

The PPS here IMO won't run on Rx Revenue, but even with the slightest hint of a partnership with a Mid to Large biotech... it'll trade way higher.


BTW:- Anyone here in touch with the company needs to tell them to PATENT (Method Claim at least) the COMBO of ABBIE + CoStar (RBC Membrane).
This will prevent anyone else from leveraging on this combo.

[ChartTRACKER]

$SHMN: MPSTOCK : My Revenue guesstimate is based on the Honorable Leader's OWN projections👇

I'm only factoring in 10% of his "Projections" (Filthy Lies).
Time to put up or GTFO

It is in a preliminary stage but aligns with the company’s growth plan and rebranding strategy. The company has projected $10,000,000 in annual gross sales over the next 12 months. $SHMN (2/2)

— SOHM, Inc. (@sohminc) July 28, 2022

SOHM Inc. is pleased to announce that based on the successful completion of previous orders, the company has received new forecasting and orders estimated at $750,000 for the next 3 quarters from one of the customers. $SHMN

— SOHM, Inc. (@sohminc) March 15, 2022

[MPstock]

I have a friendly bet with another SOHM investor that revenue will be 370 k and his guess is 1.2 million
Might as well have a little fun here

[hardlesson]

*takes me back. :)

[hardlesson]

"Getting out over their skis."

Tales me back to my younger days on the slopes. Used to do that regularly, all speed and not enough skill/technique. I'm assuming you've had some fun on the powder up in your corner of the US.

Agree with your assessment too, regarding the whole deal with Dhan M.

HL. Shmn

[Myth]

Hey JD, isn't a Definitive Agreement required to be disclosed as a Material Event within 4 business days ?

The fact ( as I understand it ) that either company can still bail is what puzzles me, in this case I heard the seller here demanded a higher price at closing.

What even puzzles me more is that SHMN didn't just inform the public of what actually happened, when it happened. With the share count not changing what would be the purpose of being silent as the shareholders are staring in disbelief ?

Unless the goal is to pump

[ChartTRACKER]

$SHMN: If they partner with a LARGE Pharma-BioTech, regarding ABBIE...

The Sky's the limit. CoStar + ABBIE is a winning combo.👇️
So they will be able to attract mid-size to Large Bio-TECHs for licensing + Partnership.

https://interestingengineering.com/health/regain-hearing-new-gene-therapy?utm_source=facebook&utm_medium=article_image

[SLC-JD]

To be fair, M&A is difficult, and is frequently derailed at the last minute. I've been involved in more than one near miss involving much larger, better established, and more successful organizations.

Their biggest failing is getting out over their skis before the material deal terms were solidified. Unless the goal is to pump, it's always better for a pubco to wait to disclose these types of transactions until there is greater clarity/more likelihood of closing.

[SLC-JD]

Honestly, I don't even know. It has been so difficult to differentiate fantasy from reality in the past forward looking statements that I feel like there is no solid basis to predict what success might look like.

I'll stick with "an uptick in revs, continued investment in next gen opportunities, and an honest appraisal/review of prior predictions".

That said, a much better measure of success would be "whatever is necessary to persuade new investors to pull the trigger".

[ChartTRACKER]

$SHMN: Nostalgia Anyone? Probably TOP TEN of AHole Barron's lies👇️

I specifically like the "Stay away from misinformation"...

As previous stated acquisition is on track, both companies have signed definitive agreement. The company will share the details at appropriate time in near future. The Company's operation is in line with its outlook & growth strategy. Stay away from misinformation $SHMN #SOHMINC

— SOHM, Inc. (@sohminc) November 4, 2021

We'll see if he's FINALLY tweeting Truthfully [at least marginally]!!

[Myth]

so I guess you don't think maybe this was the reason for the pathetic 4th qtr, the lowest rev's posted in a qtr in how long ?

imo you are half right, just lagging behind because that fits your agenda here..

spending more now on personnel and setting up facilities.

imo there was a reason for the bad number, which in turn will show up in q1...

[MDPennyPlayer]

1.2 to 1.5 million in revs? With what products???? Remember when they had "container loads" of product going out and only showed about 30k for it?

Prepare to be severely disappointed?

[ChartTRACKER]

$SHMN: MPStock: To take a Reasonable attempt to answer this....

One would need to Step back to Jan-Feb '24 time frame. And reference👇️ this 'X'

Subject: Exciting News – CDMO Orders for Skincare Products to the Dominican Republic!

Dear Stakeholders,

We are thrilled to announce that yesterday, we received significant CDMO (Contract Development and Manufacturing Organization) orders for the export of two of our premium…

— SOHM, Inc. (@sohminc) February 8, 2024

We are pleased to share some photos of our Carlsbad plant with our valued customers who have requested them. Our operations are running smoothly and we are very satisfied with the results. We anticipate a strong performance in the first quarter. Thank you for your continued… pic.twitter.com/oszy1uBCIB

— SOHM, Inc. (@sohminc) February 5, 2024

1. At that time Barron knew fully well that $SHMN's ABBIE would need $ to be put in front of Co's & Research Conf's
2. The TWO "Significant" CDMO Orders, possibly totaling >$500k [extrapolated from tweet]
3. "Our operations are running smoothly and we are very satisfied with the results. We anticipate a strong performance in the first quarter." [After 45 yrs of Fin exp & knowing fully well , that B.S. Tweets have NOT been working for TWO YEARS, one expects Substantive statements from a CEO]
4.. Jap Co's tweet Mar 19th [Unless they came up for Nothing, I'd say expect something here]. At least 40x the trips expenses for Aguilar [~$500k]/ QTR ? Or Yr?
5. Misc- $100k [Rx]
6. ABBIE [This is/will be Significant, if they've got the ball rolling. The V.C Associated with CoStar has a lot of connections, as I previously posted...let's see]

So I would guesstimate it to be:- ~ $1.2M....to $1.5M

[MPstock]

So what’s considered a strong Q1 in everyone’s opinion?
500k. 1 million. 1.5 million

[SLC-JD]

IMHO, we're still at the point where the impact of revenue greatly outweighs profits. Hell, I was actually happy to see that spending more than offset the meager revenues, and frankly I'd rather see a further decline in net earnings if it was in the context of radically increased revenue and a substantial uptick in infrastructure investment/COGS. One of the biggest issues with SHMN for as long as I've been involved is a lack of actual sales. Infrastructure spending is often a short term investment (hence many microcap companies touting their EBITDA/Adjusted EBIDTA rather than earnings), and COGS tends to decline with experience. Actually demonstrating that you can generate revenue is priceless.

I have zero information to base an opinion on what the numbers might look like, but past performance makes me at least a bit skeptical...it seems that each quarter we have wonderful outlook followed by meh, so I remain firmly in Missouri right now...Show Me.

Given the lack of volume despite numerous cheery announcements, I can only imagine that the broader investment community feels much the same.

[hardlesson]

4Q last year ($19,025) would certainly be disappointing. I'm taking them at their word, a "strong" 1Q.

...based on the Tweets in my last post.

We'll see in a few days.

hL shmn

[MDPennyPlayer]

I don't see anything that happened last quarter that would make me believe that the revenue would be much different than Q4 of last year. If anything, i'd assume the net income could be less if they are spending more now on personnel and setting up facilities.

[hardlesson]

Good question, I have a figure in mind, how about your estimate?

We are pleased to share some photos of our Carlsbad plant with our valued customers who have requested them. Our operations are running smoothly and we are very satisfied with the results. We anticipate a strong performance in the first quarter. Thank you for your continued… pic.twitter.com/oszy1uBCIB

— SOHM, Inc. (@sohminc) February 5, 2024

Subject: Exciting News – CDMO Orders for Skincare Products to the Dominican Republic!

Dear Stakeholders,

We are thrilled to announce that yesterday, we received significant CDMO (Contract Development and Manufacturing Organization) orders for the export of two of our premium…

— SOHM, Inc. (@sohminc) February 8, 2024

We are pleased to announce that we have a new stock of Levetiracetam, a medication used to treat various types of seizures in epilepsy. Levetiracetam is available in different formulations, such as tablets, liquid, and injection. It is a generic drug that is also sold under the… pic.twitter.com/5RigMTX4OZ

— SOHM, Inc. (@sohminc) February 8, 2024

hL shmn

[MDPennyPlayer]

What would be seen as "a good one" revenue wise this quarter?

[hardlesson]

1Q 2023 was $52,000, they filed it on May 11, 2023:

https://www.otcmarkets.com/otcapi/company/financial-report/369721/content

___
If they are going to get to "a few million" in Revs this year, this 1Q needs to be a good one. Then ramp up as the year progresses.

https://www.otcmarkets.com/stock/SHMN/news/SOHM-Announces-Business-Outlook-for-2024?id=423706

Baron and Dr. David...let's hear about the orders, and the San Diego facility. Thx. hL shmn

[hardlesson]

Eddie Chung (Coastar) at Bio 2024 on June 2, 2024:

Cell and Gene Therapy and Genome Editing

https://convention.bio.org/sessions/coastar-therapeutics-inc-1?&filters.type=CP&filters.TYPE=CP&searchgroup=libraryentry-sessions

https://www.linkedin.com/in/chungeddie/recent-activity/all/

Also at: https://bcic.bio.org/program/company-presentations?sp_sn=linkedin&spclid=FFC3D955-7493-42EA-AD70-6AC676F523B8

___
hL shmn

[MDPennyPlayer]

Ask and you shall receive. SHMN just tweeted exactly what you described.

“Red blood cell carriers revolutionize genome editing”#SOHMInc #redbloodcell #revolutionize #Genomediting #medicalreserach #SOHM #PharmacyTrends #MedicineTrends #Infographic #coastartherapeutics #cas9 #crispr #geneediting#Genomeadvantages $SHMN pic.twitter.com/hLHaqCCGZO

— SOHM, Inc. (@sohminc) May 9, 2024

[MDPennyPlayer]

Getting some volume today

[ChartTRACKER]

$SHMN: Wondering when the next ChatGPT lesson on Gene-Editing will be tweeted...
Anytime in the next '2' hours.
It's Soooooo....Exciting!

'F'kng Ahole Barron get your rear end moving & tweet about REVENUE & POs. especially about ABBIE
And WTF are your sales & mktg team doing? Oh wait...they're all Molecular biology experts🤔 They don't have time to sell Rx.
Are you planning to PR on 05/15...Talking about how great the EOY '24 will be?
And then PUNT to 2025?

Or are you FINALLY going to show TANGIBLE PROGRESS, the kind that moves the PPS UPWARDS?

[MDPennyPlayer]

We'll get a peek behind the curtain next week when the Q1 financials hit.

[ChartTRACKER]

$SHMN: MPStock: The "Science Advisor"...Mark Stevens...decided to get INVESTED here

He bought a few SHS 😂

Put your $ where your mouth is M-Fkers! [Everybody except Dr. Bhat]

[MPstock]

Pretty good volume today

[Myth]

Tweet

https://www.linkedin.com/pulse/improving-genome-editing-systems-medicine-red-blood-cell-membranes-hmtcc/?trackingId=BajwtsrY%2BB88e9sIyKX30Q%3D%3D

[Myth]

Time for some News here.....

[ChartTRACKER]

$SHMN: HL: Definitely they [CoStar + SoHM] have an Investment from
some deep pockets [Bio-Tech PubCo?]

Don't read too much into this.....
I noticed that the V.C. who comes up as part of the company [CoStar] : Haolin Sung from Taiwan, is also funding BioEclipse Therapeutics.
I personally know someone from BioEclipse [Startup Co]
Both could be bagging some POs from a PubCo.Illumina [$ILMN] comes up on pubs & Recent Research on mRNA delivery using Red-Blood Cell Membranes, as CoStar is currently doing.

I think $SHMN is close to putting out a PR. Let's see......

[__SmartMoney__]

I posted your link to the Biospace article on X

[hardlesson]

This MOU with Coastar is heating up imo:

This is the 3rd time they have Tweeted about it, and referenced the PR.

Discover the power within: From editing genes to enhancing delivery, discover how red blood cells are revolutionizing medicine.

Click through to the press release:https://t.co/xsAsgwgizY#GeneEditing #RedBloodCells #MedicalInnovation $SHMN#biotech #cancerresearch #invivo… pic.twitter.com/mUUnJxgiaf

— SOHM, Inc. (@sohminc) May 1, 2024

I didn't realize the PR was also on Biospace: https://www.biospace.com/article/releases/sohm-inc-and-coastar-therapeutics-sign-mou-and-announce-collaboration-to-revolutionize-genome-editing-using-red-blood-cell-membrane-derived-carriers/

Their Science Advisor is Tweeting/Reposting about it now. (The same guy that was with them at AACR)

Now the infographics contain both the Sohm and Coastar name and "Logo's."





____
hL shmn

[hardlesson]

Put down your highlighter, and go look at his resume on LinkedIn....Then tell me if you're impressed with the guy. The fact that he's here and Tweeting anything related to $shmn is a good thing, imo.

Unless you'd like to post your personal Twitter profile here, and your LinkedIn resume showing your stellar scientific credentials? I know you won't, but then again, I won't either. :)

hL. Shmn

[MDPennyPlayer]

Wow... so impressive.... That's going to get the ball rolling here...

[hardlesson]

https://x.com/DrMarkScience?t=-Oqa9rk7_LCG70xvIgg3Uw&s=09

[hardlesson]

https://t.co/bAjtHb3DXa

— Mark S (@DrMarkScience) April 30, 2024

[hardlesson]

Guess who replied to this Tweet?

https://t.co/bAjtHb3DXa

— Mark S (@DrMarkScience) April 30, 2024

[hardlesson]

Did you know red blood cell membranes can be used to deliver gene editing tools safely into our cells? This innovative approach could revolutionize treatments for genetic disorders! #GenomeEditing #HealthInnovation $SHMN pic.twitter.com/GsFk6IyNQX

— SOHM, Inc. (@sohminc) April 30, 2024

[MDPennyPlayer]

What kind of numbers are expected in the Q1 financials? I can't imagine it will be anything much from the ordinary low numbers.

[Myth]

I would think those would wait until at least Thursday to throw in the towel, but who knows....

I am anxious to see Q1 also, especially after they already hinted it would be good.....

[hardlesson]

Looks more like impatient traders to me. Selling to break even and send their money elsewhere. Maybe they can't see the bids at .0011... the 1Q is coming in 2 weeks, even if there's no news to pacify them.

In Aguilars recent interview, he hinted at 'more info to come.' Who knows what it will be, but I'm banking on this being a good start to 2024 for them.

HL. SHMN